glp-1 cardiovascular outcomes 2025 news Risks after Discontinuation Results of cardiovascular outcomes trials
Description
S., Tomasi D., and Telang F., Addiction: Beyond Dopamine Reward Circuitry, Proceedings of the National Academy of Sciences of the United States of America 108, no
Understanding the mechanistic differences between albuminuric and non-albuminuric DKD enables more tailored therapeutic interventions
these can be used to help identify what might be contributing to any adverse symptoms
Diabetes 53: 513, 2004
The purpose of medication, when appropriate, is not to replace healthy habits
Accessed March 30, 2026
